Pathogenesis of osteoporosis in liver cirrhosis

Hepato-Gastroenterology

Volumn 53, Issue 72, 2006, Pages 938-943

  Giouleme, Olga I ^a,b   Vyzantiadis, Timoleon A ^a   Nikolaidis, Nikolaos L ^a   Vasiliadis, Themistoklis G ^a   Papageorgiou, Athanasios A ^a   Eugenidis, Nikolaos P ^a   Harsoulis, Fedon I ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NONE   (Greece)

Author keywords

25 hydroxyvitamin D; Bone mineral density; Hypogonadism; Insulin like growth factor I; Liver cirrhosis

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; CORTICOSTEROID DERIVATIVE; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; OSTEOCALCIN; PARATHYROID HORMONE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; TESTOSTERONE; VITAMIN D;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE DENSITY; BONE METABOLISM; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BONE DENSITY; CASE-CONTROL STUDIES; FEMALE; GONADS; HORMONES; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE;

EID: 33845224080     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Sherlock S, Dooley J: Hepatic cirrhosis. In: Sherlock S, Dooley J (Eds.). Diseases of the liver and Biliary System. 9th Edition. Oxford: Blackwell scientific publication. 1993; pp. 72-85.
2. Mawer EB, Klass HJ, Warnes TW, Berry JL: Metabolism of vitamin D in patients with primary biliary cirrhosis and alcoholic liver diseases. Clin Sci 1985; 69:561-570.
3. Compston JE: Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease. Gut 1986; 27:1073-1090.
4. Krawitte EL, Grundman MJ, Marver EB: Absorption, hydroxylation and excretion of vitamin D3 in primary biliary cirrhosis. Lancet 1977; 2:1246-1249.
5. Kehayoglou AK, Holdsworth CD, Agnew JE, Whelton MJ, Sherlock S: Bone disease and calcium absorption in primary biliary cirrhosis. Lancet 1968; 1:715-719.
6. Compston JE, Thompson RPH: Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis. Lancet 1977; 1:721.
7. Hodgson SF, Dickson ER, Wahner HW, Johnson KA, Mann KG, Riggs BL: Bone loss and reduced osteblast function in primary biliary cirrhosis. Ann Intern Med 1985; 103:855-860.
8. Fitz G: Systemic complications of liver disease. In: Fedman M, Scharschmidt B, Sleisenger M (Eds.). Gastrointestinal and liver disease. 6th Edition. Philadelphia: WB Saunders, 1997; pp. 1334-1354.
9. Sudhaker RD, Mahalakshmi H: Metabolic bone disease in gastrointestinal, hepatobiliary, and pancreatic disorders. In: Favus M (Ed.). Primer on the metabolic bone diseases and disorders of mineral metabolism. Philadelphia: Lippincott Raven. 1996; pp. 306-311.
10. Katz IA, Epstein S: Perspective in post-transplantation bone disease. J Bone Min Res 1992; 7:123-126.
11. Navasa M., Monegal A, Guanabens N, et al: Bone fractures in liver transplant patients. Br J Rheumatol 1994; 33:52-55.
12. Hawkins FG, Leon M, Lopez MB, et al: Bone loss and turnover in patients with transplantation. Hepatogastroenterology 1994; 41:158-161.
13. Gallego-Rojo F, Gonzalez-Calvin J, Munoz-Torres M, Mundi J, Fernandez-Perez R, Rodrigo-Moreno D: Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998; 28:695-699.
14. Ormarsdottir S, Ljunggren O, Mallmin H, Brahm H, Loof L: Low body mass index and use of corticosteroids, but not cholestasis, are risk factors for osteoporosis in patients with chronic liver disease. J Hepatol 1999; 31:84-90.
15. Crawford B, Kam C, Donaghy A, Gleeson M, McCaughan G: Metabolic bone disease in cirrhosis. 5th European Congress of Endocrinology 2000, Turin, Italy.
16. Tsuneoka K, Tameda Y, Takase K, Nakano T: Osteodystrophy in patients with chronic hepatitis and liver cirrhosis. J Gastroenterol 1996; 31:669-678.
17. Hay JE, Lindor K, Wiesner RH, Dickson ER, Krom RA, LaRusso NF: The metabolic bone disease of primary sclerosing cholangitis. Hepatology 1991; 14:257-661.
18. Diamond TH, Stiel D, Lunzer M, McDowall D, Eckstein RP, Posen S: Osteoporosis and skeletal fractures in chronic liver disease. Gut 1990; 31:82-87.
19. Bonkovsky HL, Hawkins M, Steinberg K, Hersh T, Galambos JT, Henderson JM, et al: Prevalence and prediction of osteopenia in chronic liver disease. Hepatology 1990; 12:273-280.
20. McDonald JA, Dunstan CR, Dilworth P, Sherbon K, Sheil AG, Evans RA, et al: Bone loss after liver transplantation. Hepatology 1991; 14:613-619.
21. Arnold JC, Hauser D, Ziegler R, Kommerell B, Otto G, Theilmann L, et al: Bone disease after liver transplantation. Transplant Proc 1992; 24:2709-2710.
22. Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez de Osaba MJ, et al: Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 1997; 60:148-154.
23. Ziegler R: Osteoporose. Schweiz Rundsch Med Prax 1994; 83(38):1051-1055.
24. Rose J, Compston JE, Crawley EO, et al: Osteoporosis associated with chronic liver disease. Eur J Gastroenterol Hepatol 1991; 3:63-69.
25. Janes CH, Dickson ER, Okazaki R, Bonde S, McDonagh AF, Riggs BL: Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 1995; 95:2581-2586.
26. Chappard D, Plantard B, Fraise H, Palle S, Alexandre C, Riffat G: Bone changes in alcoholic cirrhosis of the liver. A histomorphometric study. Pathol Res Pract 1989; 18:480-485.
27. Peris P, Pares A, Guanabens N, Del Rio L, Pons F, Martinez de Osaba MJ, et al: Bone mass improves in alcoholics after two years of abstinence. J Bone Miner Res 1994; 9:1607-1612.
28. McCaughan GW, Feller RB: Osteoporosis in chronic liver disease:pathogenesis, risk factors, and management. Dig Dis 1994; 12:223-231.
29. Diamond T, Stiel D, Mason R, Lissner D, Bikle D, Wilson S, et al: Serum vitamin D metabolites are not responsible for low turnover osteoporosis in chronic liver disease. J Clin Endocrinol Metab 1989; 69:1234-1239.
30. Diamond TH, Stiel D, Lunzer M, McDowall D, Eckstein RP, Posen S: Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease. Gastroenterology 1989; 96:213-221.
31. Plourde V, Gascon-Barre M, Coulombe P, Vallieres S, Willems B, Huet PM: In chronic liver disease the C-25 hydroxylation of vitamin D3 depends on the functional mass and not on the presence of cholestasis. Hepatology 1987; 7:1053.
32. Jones JJ, Clemmons DR: Insulin-like growth factors and their binding proteins:biological actions. Endocr Rev 1995; 16:3-34.
33. Assy N, Hochberg Z, Amit T, Shen-Orr Z, Enat R, Baruch Y: Growth hormone-stimulated insulin-like growth factor(IGF)I and IGF-binding protein-3 in liver cirrhosis. J Hepatol 1997; 27:796-802.
34. Donaghy A, Ross R, Gimson A, Hughes SC, Holly J, Williams R: Growth hormone, insulinlike growth factor-1 and and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease. Hepatology 1995; 21:680-688.
35. Santolaria F, Gonzalez-Gonzalez G, Gonzalez-Reimiers, et al: Effects of alcool and liver cirrhosis on the GH-IGF-1 axis. Alcohol Alcohol 1995; 30:703-708.
36. Caregaro L, Alberino F, Amodio P, Merkel C, Angeli P, Plebani M, et al: Nutritional and prognostic significance of insulin-like factor 1 in patients with liver cirrhosis. Nutrition 1997; 13:185-190.
37. Wuster C, Blum WF, Schlemilch S, Ranke MB, Ziegler R: Decreased insulin-like growth factors and and IGF binding protein 3 in osteoporosis. J Intern Med 1993; 234:249-255.
38. Johannsson AG, Forslund A, Hambraeus L, Blum WF, Ejunghall S: Growth hormone, dependent insulin like growth factor binding proteins is a major determinant of bone mineral density in healthy men. J Bone Miner Res 1994; 9:915-921.
39. Wang YJ, Wu JC, Lee YT, Tsai KJL: Gonadal dysfunction and changes in sex hormones in postnecrotic cirrhotic men: a matched study with alcoholic cirrhotic men. Hepatogastroenterology 1991; 38:531-534.
40. Maruyama Y, Adachi Y, Aoki N, Suzuki Y, Shinohara H, Yamamoto T: Mechanism of feminization in male patients with non-alcoholic liver cirrhosis: Role of sex hormone binding globulin. Gastroenterol Jpn 1991; 26:435.
41. Cavanaugh J, Niewoeher CB, Nuttall FQ: Gynecomastia and cirrhosis of the liver. Arch Intern Med 1990; 150:563.
42. Kaymakoglu S, Okten A, Cakaloglu Y, Boztas G, Besisik F, Tascioglu C, et al: Hypogonadism is not related to the etiology of cirrhosis. J Gastroenterol 1995; 30(6):745-750.
43. Mooradian AD, Shamma M, Salti I, Cortas N: Hypophyseal-gonadal dysfunction in men with non-alcoholic liver cirrrhosis. Andrologia 1985; 17:72-79.
44. Handelsman D, Strasser S, McDonald JA, Conway AJ, McCaughan GW: Hypothalamic- pituitary-testicular function in end-stage non-alcoholic liver disease before and after liver transplantation. Clin Endocrinol 1995; 43:331.
45. Molitich ME: Pathologic hyperprolactinemia. Endocrinol Metab North Am 1992; 21:877.
46. Foreani A, Mega A, Tizian L, Burra P, Boccagni P, Baldo V, Fagiuoli S, Naccarato R, Luisetto G: Bone metabolism and gonad function in male patients undergoing liver transplantation: a two-year longitudinal study. Osteoporos Int 2001; 12:749-754.